NCT03840941

Brief Summary

The investigators aim to demonstrate whether balance, cognition and activities of daily living have changed in COPD patients with and without frailty.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2018

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

February 12, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 15, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2019

Completed
Last Updated

December 1, 2023

Status Verified

November 1, 2023

Enrollment Period

1.6 years

First QC Date

February 12, 2019

Last Update Submit

November 30, 2023

Conditions

Keywords

COPDFrailtyBalanceCognitionActivities of Daily Living

Outcome Measures

Primary Outcomes (4)

  • Presence of The Frailty Will Be evaluated Using The Frailty Criteria by Fried

    Frailty will be identified by the presence of three or more of the following criteria unintentional weight loss (10 Ibs in past year), weakness (grip strength), self-reported exhaustion, slow walking speed and low physical activity. Patients with three or more of the criteria present were classified as frail.

    1st Day

  • Balance Assessment Using Functional Reach Test

    The Functional Reach Test measures how far patient can reach forward from a normal relaxed stance.

    1st Day

  • Cognition Using MoCA-Test

    Cognitive function will be evaluated with the secreening tool the Montreal Cognitive Assessment (MoCA). The MoCA is a 30-point screening tool.

    1st Day

  • Perform activities of daily living (ADL) will be evaluated using the Glittre ADL-test

    Glittre ADL-test was designed specifically to assess the functional limitation in patients with COPD. Glittre ADL-test time will be considered the main outcome variable, and will be recorded in minutes (metric).

    1st Day

Secondary Outcomes (4)

  • Exercise Capacity Using 6-Minute Walk Test

    1st Day

  • Disease-Related Quality of Life Assessment

    1st Day

  • Respiratory Muscle Strength Assessment

    1st Day

  • Shortness of Breath Assessment

    1st Day

Study Arms (2)

Frail patients with COPD

No intervention

Non-frail patients with COPD

No intervention

Eligibility Criteria

Age55 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Individuals who are diagnosed with COPD at Hacettepe University and who are referred to the Cardiopulmonary Rehabilitation Unit for physiotherapy also who are willing to participate in the study will be included in the study.

You may qualify if:

  • COPD patients who have been clinically stable for the last four weeks and who have not undergone drug change for the last four weeks
  • Being 55 years of age or older
  • Accepted to participate in the study (Able and wililing to complete the informed consent process)
  • Co-operate
  • Patients with COPD who are ambulant without support or an assistive device

You may not qualify if:

  • Neurological, cardiac or orthopedic diseases
  • Other chronic diseases that may affect balance and walking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation

Ankara, Sihhiye, 06100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveFrailty

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Deniz Inal-Ince, PhD

    Hacettepe University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

February 12, 2019

First Posted

February 15, 2019

Study Start

March 1, 2018

Primary Completion

October 15, 2019

Study Completion

October 15, 2019

Last Updated

December 1, 2023

Record last verified: 2023-11

Locations